Syros Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2025 | 113 | $24 | 100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 08/07/2025 | 0 | $0 | -100.00% | 0.00% |
| BAADER BANK AKTIENGESELLSCHAFT | 07/10/2025 | 0 | $0 | -100.00% | 0.00% |
| 1492 CAPITAL MANAGEMENT LLC | 08/13/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Syros Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Syros Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ADVISOR GROUP HOLDINGS, INC.: 0
BlackRock Inc.: 259,189
CHI Advisors LLC: 1.3 M
First Capital Advisors Group, LLC.: 1,123
Cowen Prime Advisors LLC: 13
Ten Capital Wealth Advisors, LLC: 0
0.00% of Syros Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.70 M shares in the last 24 months. This purchase volume represents approximately $785.53 K in transactions.